TheManInTheShack

TheManInTheShack t1_iutplya wrote

> CONCLUSIONS In this phase 2 trial involving participants with treatment-resistant depression, psilocybin at a single dose of 25 mg, but not 10 mg, reduced depression scores significantly more than a 1-mg dose over a period of 3 weeks but was associated with adverse effects. Larger and longer trials, including comparison with existing treatments, are required to determine the efficacy and safety of psilocybin for this disorder.

I’m surprised by this finding because the adverse effects listed don’t seem typical for recreational use.

21